Endocyte, Inc v. Point Biopharma Global Inc
Endocyte, Inc v. Point Biopharma Global Inc is a federal patent lawsuit filed on 06/13/2024 in the District Court, S.D. Indiana. The case was terminated on 07/18/2025.
- Court
- District Court, S.D. Indiana (S.D. Ind.)
Official Court Website → - Assigned judge
- Richard L. Young · 13,597 cases in index
- Docket number
- 1:24-cv-01011
- Cause
- 35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement - Nature of suit
- 830 Patent
Infringement of a patented invention. - Jurisdiction
- Federal Question
- Jury demand
- Plaintiff
- Date filed
- 06/13/2024
- Date terminated
- 07/18/2025
630 Patent cases in this court are indexed here.
Parties
- plaintiff · Endocyte, Inc · 5 cases
- defendant · Point Biopharma Global Inc · 3 cases
Part of a Larger Litigation Pattern
This is one of 4 Patent cases in our index naming Point Biopharma Global Inc — a possible mass-tort or coordinated-litigation cluster.
About Patent Lawsuits
Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.
Frequently Asked Questions
What is Endocyte, Inc v. Point Biopharma Global Inc?
Endocyte, Inc v. Point Biopharma Global Inc is a federal patent lawsuit filed on 06/13/2024 in the District Court, S.D. Indiana. The case was terminated on 07/18/2025. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.
What type of case is this?
It is classified as “Patent” under the federal nature-of-suit system. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.
What court is the case in?
The case is in the District Court, S.D. Indiana, docket number 1:24-cv-01011.
When was the case filed?
Endocyte, Inc v. Point Biopharma Global Inc was filed on 06/13/2024. It was terminated on 07/18/2025.
What law is the case brought under?
The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.
Other Cases Involving These Parties
Related Patent Cases
Source: public U.S. federal court record (docket 68854532).